{
  "trial_id": "NCT02382016",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, baseline pulmonary vascular resistance (PVR), systolic blood pressure (SBP), ALT levels, AST levels, bilirubin levels, presence of severe hepatic impairment, presence of severe obstructive or restrictive lung disease, presence of pulmonary veno-occlusive disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Pulmonary vascular resistance (PVR) at baseline (calculated)",
          "baseline pulmonary vascular resistance (PVR)"
        ],
        [
          "Systolic blood pressure (SBP)",
          "systolic blood pressure (SBP)"
        ],
        [
          "ALT/AST >= 3 x ULN",
          "ALT levels"
        ],
        [
          "ALT/AST >= 3 x ULN",
          "AST levels"
        ],
        [
          "Bilirubin >= 3 mg/dL at Screening",
          "bilirubin levels"
        ],
        [
          "Severe hepatic impairment",
          "presence of severe hepatic impairment"
        ],
        [
          "Severe obstructive or restrictive lung disease",
          "presence of severe obstructive or restrictive lung disease"
        ],
        [
          "Pulmonary veno-occlusive disease",
          "presence of pulmonary veno-occlusive disease"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Pulmonary arterial hypertension (PAH)-specific therapy",
        "Body Mass Index (BMI) at baseline",
        "Time since portal hypertension diagnosis",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": []
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Pulmonary Vascular Resistance (PVR), Systolic Blood Pressure, ALT, AST, Bilirubin, Severity of Hepatic Impairment, Severity of Lung Disease, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Pulmonary vascular resistance (PVR) at baseline (calculated)",
          "Baseline Pulmonary Vascular Resistance (PVR)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Pulmonary arterial hypertension (PAH)-specific therapy",
        "Body Mass Index (BMI) at baseline",
        "Time since portal hypertension diagnosis",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": [
        "Systolic Blood Pressure",
        "ALT",
        "AST",
        "Bilirubin",
        "Severity of Hepatic Impairment",
        "Severity of Lung Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Pulmonary Vascular Resistance, Liver Function Tests, Bilirubin, ALT/AST Ratio,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI) at baseline",
          "Body Mass Index"
        ],
        [
          "Pulmonary vascular resistance (PVR) at baseline (calculated)",
          "Pulmonary Vascular Resistance"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race/Ethnicity",
        "Pulmonary arterial hypertension (PAH)-specific therapy",
        "Time since portal hypertension diagnosis",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Liver Function Tests",
        "Bilirubin",
        "ALT/AST Ratio"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, weight, height, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, liver function tests (ALT, AST, bilirubin), pulmonary function tests (FEV1, FVC), 6-minute walk distance, World Health Organization (WHO) functional class, New York Heart Association (NYHA) functional class, medical history (including liver disease, lung disease), concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index (BMI) at baseline",
          "body mass index (BMI)"
        ],
        [
          "Systolic blood pressure (SBP) < 90 mmHg at Screening",
          "systolic blood pressure (SBP)"
        ],
        [
          "ALT/AST >= 3 x ULN",
          "liver function tests (ALT, AST, bilirubin)"
        ],
        [
          "Pulmonary vascular resistance (PVR) at baseline (calculated)",
          "pulmonary function tests (FEV1, FVC)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Pulmonary arterial hypertension (PAH)-specific therapy",
        "Time since portal hypertension diagnosis",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "diastolic blood pressure (DBP)",
        "heart rate",
        "6-minute walk distance",
        "World Health Organization (WHO) functional class",
        "New York Heart Association (NYHA) functional class",
        "medical history (including liver disease, lung disease)",
        "concomitant medications."
      ]
    }
  }
}